Bausch Health issues Q1 2023 earnings; filing lacks specific figures

Bausch Health Companies Inc.

2023-Q1 EPS reported -$0.55 revenue$1,944,000,000

Results reported for quarter ended March 31, 2023, in press release dated May 4, 2023.
No revenue, EPS, or segment data can be extracted from the provided filing excerpt.
Investors should obtain the full press release (Exhibit 99.1) for complete financial details.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Bausch Health Companies Inc. reported financial results for the quarter ended March 31, 2023.

Period: the quarter ended March 31, 2023
Result: reported results

Exact text from the filing

On May 4, 2023, Bausch Health Companies Inc. (the "Company") issued a press release announcing results of operations for the quarter ended March 31, 2023 and certain other financial information as of and for the quarter ended March 31, 2023.

View on SEC.gov

Browse all earnings releases →

Bausch Health Companies Inc. filing history →

Source: SEC EDGAR

accession 0000885590-23-000016

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.